Ajax-Loading

Takeda Pharmaceutical Co. Ltd. - Intagible Assets

Takeda Pharmaceutical Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Trillions.

The item "Intagible-Assets" stands at 3.30 Trillion Japanese Yens as of 09/30/2025, the lowest value since 03/31/2019.

As of the end of Takeda Pharmaceutical Co. Ltd.'s second quarter, the item "Intagible Assets" stands at 3.30 Trillion JPY. This represents a decrease of -3.60 percent compared to it's value at the end of it's first quarter .


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -12.50 percent compared to the value the year prior.
The 1 year change in percent is -12.50.
The 3 year change in percent is -21.20.
The 5 year change in percent is -14.93.
The 10 year change in percent is 270.68.

The Serie's long term average value is 2.32 Trillion Japanese Yens. It's latest available value, on 09/30/2025, is 42.34 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 06/30/2011, to it's latest available value, on 09/30/2025, is +1,070.93%.
The Serie's change in percent from it's maximum value, on 03/31/2019, to it's latest available value, on 09/30/2025, is -32.12%.

Intagible Assets for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Intagible Assets905,699,262,464.00
LogoJohnson & Johnson - Intagible Assets486,508,953,600.00
LogoAbbVie Inc - Intagible Assets399,570,305,024.00
LogoRoche Holding AG - Intagible Assets317,433,206,677.55
LogoAstraZeneca PLC - Intagible Assets280,205,508,085.11